Paper Review Records
All Paper Review Records
19 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
109
days
From budget constraints to value-based payment: an incremental cost-effectiveness analysis of sacituzumab tirumotecan for advanced triple-negative breast cancer in China
Authors
Shaohong Luo; Xiangzhen Wang; Lijing Yang; Shen Lin; Xiaoting Huang; Xiuhua Weng; Xiongwei XuShow moreShow less
Affiliations
1. Fujian Medical University; 2. Mengchao Hepatobiliary Hospital of Fujian Medical UniversityShow moreShow less
116
days
Pembrolizumab trough concentration monitoring and association with outcomes in advanced non-small cell lung cancer
Authors
Ioannis P. Trontzas; Anastasia Palaiologou; Natalia Kamperi; Anastasia Georganta; Emmanouil Panagiotou; Ioanna-Maria Orfanou; Konstantinos G. Kyriakoulis; Ioannis Vathiotis; Elias A. Kotteas; Dimitra Grapsa; Constantin Tamvakopoulos; Konstantinos N. SyrigosShow moreShow less
Affiliations
1. National and Kapodistrian University of Athens; 2. Biomedical Research Foundation, Academy of AthensShow moreShow less
90
days
An evaluation of avutometinib in combination with defactinib for KRAS -mutated recurrent low-grade serous ovarian cancer
Authors
Vivek Podder; Brian M. Slomovitz; Robert L. ColemanShow moreShow less
Affiliations
1. Mount Sinai Medical Center; 2. US Oncology NetworkShow moreShow less
132
days
Clinical management of oligoprogressive renal cell carcinoma
Authors
Ezra A. Bernstein; Jonathan Schoenhals; Shawn Dason; Shang-Jui Wang; Eric A. Singer; Karie RuncieShow moreShow less
Affiliations
1. Columbia University Herbert Irving Comprehensive Cancer Center; 2. The Ohio State University Comprehensive Cancer CenterShow moreShow less
129
days
National Delphi consensus on perioperative and locally advanced NSCLC management in Colombia
Authors
Ricardo Bruges Maya; Milton Lombana; Carlos Andres Carvajal-Fierro; Ricardo Zapata Gonzalez; Juan Jose Ortiz Martinez; Alejandro Gonzalez-Motta; Lina Maria Loaiz SalazarShow moreShow less
Affiliations
1. Instituto Nacional de Cancerología (INC); 2. Clínica de Occidente; 3. Centro de ratamiento e Investigación sobre Cáncer (CTIC); 4. Clínica CardioVID – Clínica VIDA; 5. Hospital Universitario del Valle; 6. Clínica SomerShow moreShow less
64
days
Antibody-drug conjugates in oncology: a clinically focused review for nursing practice
Authors
Ioanna Tsatsou; Eleni Panagou; Ourania GovinaShow moreShow less
Affiliations
1. University of West AtticaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days